交易 | 地址 | 数量 |
---|---|---|
19c462...6f528d
|
the-void |
-
6.26737931 LTC
·
555.54 USD
|
19c462...6f528d
|
LcNS6c...osnkN3
|
+
6.26737931 LTC
·
555.54 USD
|
19c462...6f528d
|
script-f119dc872ba33d4b0a7e9dea0bf691f6 |
+
0 LTC
·
0.00 USD
|
615151...56baae
|
ltc1q7...v7ddw5
|
-
1.06840546 LTC
·
94.70 USD
|
615151...56baae
|
MFYGZQ...dkghKg
|
+
1.06778941 LTC
·
94.64 USD
|
615151...56baae
|
the-void |
+
0.00061605 LTC
·
0.05 USD
|
cc8c03...b11346
|
Le8hS4...Lv7qvp
|
-
9.30648258 LTC
·
824.92 USD
|
cc8c03...b11346
|
LfUdt8...CuVGo4
|
+
3.57696434 LTC
·
317.06 USD
|
cc8c03...b11346
|
LefNu7...W8ukhb
|
+
5.72884024 LTC
·
507.80 USD
|
cc8c03...b11346
|
the-void |
+
0.000678 LTC
·
0.06 USD
|
MEI Pharma completes $100 million private placement to purchase Litecoin as reserve asset, first publicly traded company to do so.
LD Capital创始人JackYi分析认为,加密货币牛市具有轮动上涨规律,山寨币可能在最后补涨。
MEI Pharma's stock surged over 33%, raising its market cap to $41.24 million. A strategic transformation led by Titan Partners Group and GSR is pushing MEI Pharma to establish a Litecoin treasury strategy.